10 reports

Filgrastim or Lenograstim or CSF##), Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF##), Interferon Gamma (Immune Interferon or IFNG), Interleukin ## Alpha (IL ## Alpha or Hematopoietin ## or IL##A), Interleukin ##

  • Respiratory Treatment
  • Therapy
  • World
  • Product Initiative
  • Windtree Therapeutics, Inc.

Neupogen (filgrastim) ##.

  • Respiratory Treatment
  • Europe
  • Demand
  • AstraZeneca PLC
  • Roche Group

Global sales of Biopharmaceuticals (including biosimilars, biopharmaceutical contract manufacturing and Glatopa) grew +##% (cc) to USD ## million, driven by strong performance of Zarxio (filgrastim) and Glatopa ##mg in the US.

  • Air Way Device
  • Respiratory Treatment
  • United States
  • Company Financials
  • GlobalData's company

Global sales of Biopharmaceuticals (including biosimilars, biopharmaceutical contract manufacturing and Glatopa) grew +##% (cc) to USD ## million, driven by strong performance of Zarxio (filgrastim) and Glatopa ##mg in the US.

  • Clinical Trial
  • Pharmaceutical
  • Pulmonary Delivery
  • Respiratory Treatment
  • GlobalData's company

Global sales of Biopharmaceuticals (including biosimilars, biopharmaceutical contract manufacturing and Glatopa) grew +##% (cc) to USD ## million, driven by strong performance of Zarxio (filgrastim) and Glatopa ##mg in the US.

  • Clinical Trial
  • Respiratory Treatment
  • United States
  • Company Financials
  • GlobalData's company

Filgrastim, New Biosimilars, and Somatropin ## Allergy Care Products.............. ## Table ##: Allergy and Rhinitis Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Allegra and Telfast, Avamys and Veramyst, Claritin and Clarinex, Zyrtec and Xyzal, and Others.....

  • Allergy Drug
  • Allergy Immunotherapy
  • OTC
  • Pharmaceutical
  • Respiratory Treatment
  • Clinical Trial profile. 1603 Trial Title
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Filgrastim or Lenograstim or CSF##), Interleukin ## (IL##), Interleukin ## (IL## or C-X-C Motif Chemokine ## or Emoctakin or Granulocyte Chemotactic Protein ## or GCP## or Monocyte Derived Neutrophil Chemotactic Factor or MDNCF or Monocyte Derived Neutrophil Activating Peptide or MONAP or Neutrop

  • Asthma
  • Clinical Trial
  • Pharmaceutical
  • Respiratory Treatment
  • World
  • Clinical Trial Profile Snapshots

FILGRASTIM OR LENOGRASTIM OR CSF##), INTERLEUKIN ## BETA (IL ## BETA OR CATABOLIN OR IL##B), INTERLEUKIN ## (CYTOKINE SYNTHESIS INHIBITORY FACTOR OR CISF OR IL##), INTERLEUKIN ## (IL##), INTERLEUKIN ## (IL##), NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN (## KDA ALPHA ## MICROGLOBULIN RELATED SUBUNI

  • Hospital
  • Respiratory Treatment
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc

The company' s key products include Neulasta (pegfilgrastim); Neupogen (filgrastim) indicated for cancer treatment; Enbrel (entanercept) for treating rheumatoid arthritis; Epogen (Erythropoietic Stimulating Agents); Aranesp (darbepoetin alfa) to treat anemia associated with chronic kidn

  • Pharmaceutical
  • Respiratory Disease
  • Respiratory Treatment
  • Therapy
  • Infinity Pharmaceuticals, Inc.

Infliximab by Nippon Kayaku (approved in 2014) and Filgrastim by Teva Pharma Japan (approved in 2013) are some of the drugs of this segment.

  • Anti-Infective
  • Respiratory Treatment
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation